Healthcare Stocks Under Review: Exelixis, (NASDAQ:EXEL), Gilead Sciences, (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY)
During Wednesday’s trade, Shares of Exelixis, Inc. (NASDAQ:EXEL), gain 1.23% to $5.32. Exelixis, Inc. (EXEL) declared the presentation of positive data from subgroup analyses of METEOR, the phase 3 pivotal trial comparing cabozantinib to everolimus in 658 patients with renal...